Skip to content

Neuralgia: clinical trials and information

Neuropathic pain is pain caused by damage to, or disease of, the nervous system. People describe it with words such as burning, shooting, stabbing or electric. It can follow conditions such as diabetes, shingles, nerve injury or chemotherapy.
2
Trials with Canadian sites
0
Recruiting in Canada
19
Registry records worldwide

Neuralgia clinical trials in Canada

2 trials, recruiting first
PhaseProvinces
Intra-operative Lidocaine Infusion in Preventing CPSP Post VATs
NCT02862769
Unknown statusPhase 4OntarioLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2017-01-01
Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain
NCT03009500
CompletedPhase 3OntarioUniversity Health Network, Toronto2017-01

Neuralgia clinical trials worldwide (outside Canada)

17 trials, 3 recruiting or not yet recruiting. Recruiting first.

PhaseCountries
Virtual Reality (VR) Self-Hypnosis Software
NCT06398847
RecruitingNot applicableUnited StatesIcahn School of Medicine at Mount Sinai2026-03-26
Perioperative Medical Program to Optimize Nerve Regeneration After Robot-assisted Laparoscopic Neurolyses of Pudendal and/or Inferior Cluneal Nerves for Chronic Neuralgias: Results After 1-year Follow-up
NCT06796595
RecruitingFranceUBOSGA2025-01-23
Treatment of Upper Limb Chronic Neuropathic Pain by Electrical Stimulation of the Brachial Plexus Nerve Roots
NCT05817786
RecruitingNot applicableFranceCentre Hospitalier Universitaire de Nice2024-02-09
Botulinum Toxin for Chronic Neuropathic Pain
NCT06036043
Unknown statusDenmarkRegion Zealand2023-08-01
Long-term Effects of Repetitive TMS in Chronic Neuropathic Pain in People With SCI
NCT05226676
WithdrawnNot applicableUnited StatesIcahn School of Medicine at Mount Sinai2023-08
Home-based EEG Neurofeedback for Chronic Neuropathic Pain
NCT05464199
CompletedPhase 1United KingdomEast Kent Hospitals University NHS Foundation Trust2022-10-06
Immersive Virtual Reality for Chronic Neuropathic Pain After Spinal Cord Injury: A Feasibility Trial
NCT04700033
CompletedNot applicableUnited StatesIcahn School of Medicine at Mount Sinai2019-07-17
Ketamine's Efficiency in the Treatment of Chronic Pain: Kynurenin Pathway
NCT03513822
Unknown statusPhase 3FranceRedar2018-02-16
Transcranial Direct Current Stimulation (tDCS) in Chronic Neuropathy
NCT02747758
TerminatedNot applicableGermanyCharite University, Berlin, Germany2016-09-19
Novel Treatment Option for Neuropathic Pain
NCT02490436
CompletedPhase 2NorwaySorlandet Hospital HF2015-10
Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain
NCT01899170
TerminatedPhase 2DenmarkUniversity of Aarhus2014-04-01
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
NCT01974791
CompletedNot applicableUnited StatesBoston Children's Hospital2013-10
Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study
NCT01298466
WithdrawnPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2012-02
A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia
NCT01124617
CompletedPhase 2JapanJanssen Pharmaceutical K.K.2010-06
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)
NCT00964990
TerminatedPhase 2Belgium, Netherlands, Spain, United StatesJohnson & Johnson Pharmaceutical Research & Development, L.L.C.2009-09
A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury
NCT00407745
CompletedPhase 3Chile, China, Colombia, Czechia and 6 morePfizer's Upjohn has merged with Mylan to form Viatris Inc.2007-01
KETOR: Effects of Peri Operative Administration of Ketamine on Long Term Post Thoracotomy Pain
NCT00224588
CompletedPhase 3FranceAssistance Publique - Hôpitaux de Paris2003-01

About Neuralgia

What is Neuralgia?

Neuropathic pain is pain caused by damage to, or disease of, the nervous system. People describe it with words such as burning, shooting, stabbing or electric. It can follow conditions such as diabetes, shingles, nerve injury or chemotherapy.

How is Neuralgia usually assessed?

Clinicians usually assess neuropathic pain through a history and a neurological examination, sometimes with questionnaires designed to screen for nerve-related pain, and sometimes with nerve conduction studies or imaging.

What kinds of treatments are studied for Neuralgia?

Registered studies cover medicines, medical devices (such as nerve stimulators), procedures (such as nerve blocks or injections), physical and movement therapies, psychological approaches (such as cognitive behavioural therapy), education programs and digital tools. Being studied in a trial does not mean a treatment works or is approved. The interventions listed on this page come directly from the registry records.

How can I find Neuralgia clinical trials in Canada?

This page lists 2 registry records for this term with at least one site in Canada, recruiting studies first. Each trial page links to the official ClinicalTrials.gov record, which lists the study contacts. Recruiting status changes often, so check the registry, and talk to your doctor before joining a study.

Related conditions

Related interventions

Related US FDA drug labels

Labels whose indications text mentions this term. US labels, not Health Canada Product Monographs.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.